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Complexation of Cm(III) with the recombinant
N-lobe of human serum transferrin studied by
time-resolved laser fluorescence spectroscopy
(TRLFS)
N. Bauer,*a,b V. C. Smith,c R. T. A. MacGillivrayc and P. J. Panaka,b
The complexation of Cm(III) with the recombinant N-lobe of human serum transferrin (hTf/2N) is investi-
gated in the pH range from 4.0 to 11.0 using TRLFS. At pH ≥ 7.4 a Cm(III) hTf/2N species is formed with
Cm(III) bound at the Fe(III) binding site. The results are compared with Cm(III) transferrin interaction at the
C-lobe and indicate the similarity of the coordination environment of the C- and N-terminal binding sites
with four amino acid residues of the protein, two H2O molecules and three additional ligands (e.g. synergis-
tic anions such as carbonate) in the first coordination sphere. Measurements at c(carbonate)tot = 0.23 mM
(ambient carbonate concentration) and c(carbonate)tot = 25 mM (physiological carbonate concentration)
show that an increase of the total carbonate concentration suppresses the formation of the Cm(III) hTf/2N




3− are formed successively with increasing pH. In general, carbonate complexation is a compet-
ing reaction for both Cm(III) complexation with transferrin and hTf/2N but the effect is significantly higher
for the half molecule. At c(carbonate)tot = 0.23 mM the complexation of Cm(III) with transferrin and
hTf/2N starts at pH ≥ 7.4. At physiological carbonate concentration the Cm(III) transferrin species II forms
at pH ≥ 7.0 whereas the Cm(III) hTf/2N species is not formed until pH > 10.0. Hence, our results reveal
significant differences in the complexation behavior of the C-terminal site of transferrin and the recombi-
nant N-lobe (hTf/2N) towards trivalent actinides.
Introduction
If radionuclides are accidentally released into the environ-
ment, they (and in particular actinides) can cause a serious
health risk upon incorporation into bodily tissues. Since they
have no essential function in the human body little is known
about the biochemistry of actinides in man. To allow the deve-
lopment of potential decontamination therapies, a detailed
understanding of the mechanisms of relevant biochemical
reactions is required.1
One potential reaction that absorbed actinides might
undergo is the coordination to human serum transferrin.
Transferrin is an iron carrier protein in blood with a molecular
mass of 79 570 Da consisting of a glycopolypeptide of 679
amino acid residues.2–4 The ternary structure of transferrin is
characterized by folding into two similar lobes which are
joined by a short peptide chain.5 Each lobe consists of two
domains separated by a cleft housing the metal binding site
for Fe(III). In both lobes Fe(III) is coordinated by two tyrosines,
one aspartate, one histidine and the synergistic anion carbonate
in a distorted octahedral geometry.6,7 Coordination of Fe(III)
and carbonate at the binding site leads to a conformational
change of transferrin from an open to a closed form. This
structural change stabilizes the transferrin metal ion complex
and is important for the recognition of the metal ion transferrin
complex by the receptor.2,8
In blood, transferrin is about 30% saturated with iron. Con-
sequently, non-saturated transferrin is available for the com-
plexation of other metal ions. Besides ferric iron about 30
other metal ions have been identified to bind to transferrin,
among them actinides such as Th(IV), Pa(V), U(VI), Np(IV), Np(V),
Pu(IV), Am(III) and Cm(III).9–20 In our previous study, the com-
plexation of Cm(III) with transferrin was studied in the pH
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range from 3.5 to 11.0 at ambient carbonate concentration.15
At pH ≥ 7.4 Cm(III) is bound at the Fe(III) binding site of
transferrin (Cm(III) transferrin species II) whereas at lower pH
a nonspecific partially bound Cm(III) transferrin species is
formed (Cm(III) transferrin species I).15 The fluorescence spec-
trum of the Cm(III) transferrin species II is in very good agree-
ment to the spectrum of Cm2Tf (Cm(III) bound at the C- and
N-terminal binding sites) and CmCTf (Cm(III) bound only at the
C-terminal binding site) observed by Sturzbecher-Hoehne et al.
at pH 8.6.16 Furthermore, the influence of carbonate on the
complexation of Cm(III) with transferrin was investigated.21 An
increase of the total carbonate concentration favors the for-
mation of the Cm(III) transferrin species II with Cm(III) bound
at the Fe(III) binding site of transferrin at significantly lower
pH values which proves directly that carbonate acts as syner-
gistic anion for Cm(III) complexation with transferrin. On the
other hand, at high carbonate concentration (25 mM) carbon-
ate complexation is an important competition reaction which
suppresses Cm(III) transferrin complex formation significantly.21
Although the binding ligands are conserved in the C- and
N-terminal binding sites of transferrin, the sites are not kineti-
cally or thermodynamically equivalent. The stability constants
for the N- and C-lobe of Fe2Tf differ significantly (log KC = 21.4
and log KN = 20.3),
22 and the difference is almost two orders of
magnitude for Cm2Tf (log KC = 8.8 ± 0.3 and log KN = 7.0 ± 0.1
at pH 8.6).16 Therefor a high excess of transferrin was used in
the previous studies to ensure exclusive coordination of Cm(III)
at the C-terminal binding site and the formation of a Cm(III)
transferrin complex with 1 : 1 stoichiometry.15,21 Only transfer-
rin in the closed conformation with two metal ions bound at
the Fe(III) binding sites can be brought into the cells via recep-
tor mediated endocytosis. Hence, it is necessary to study the
complexation of Cm(III) with transferrin at both the C- and
N-lobes to achieve detailed information on the complexation pro-
perties of the N-terminal binding site compared to the C-term-
inal site. Since the stability constant of Cm(III) coordinated at
the N-lobe of transferrin is significantly lower compared to the
stability constant of the C-lobe it is not possible to achieve the
formation of CmNTf with exclusive coordination of Cm(III) at
the N-terminal binding site. Therefor the recombinant N-lobe
of human serum transferrin (hTf/2N) which features only the
N-terminal binding site is used as a model for the N-lobe of
transferrin.
In the present study we investigate the complexation of
Cm(III) with hTf/2N. The Cm(III) hTf/2N complexation is studied
in the pH range from 4.0 to 11.0 at ambient and physiological
carbonate concentration and at room temperature as well as at
physiological temperature using time-resolved laser fluo-
rescence spectroscopy (TRLFS). This is a very sensitive method
to study complexation reactions of lanthanides and actinides
in the submicromolar concentration range.23 Cm(III) is used as
a representative for trivalent actinides because of its excellent
fluorescence properties.24 Spectroscopic parameters like shape
and position of the emission bands as well as the fluorescence
lifetime provide information on the coordination environment
of the metal ion and its complex geometry.
Experimental section
Chemicals and sample preparation
All protein samples were prepared in Tris-HCl (tris(hydroxy-
methyl)aminomethane) buffered solutions (10 mM, pH 7.4)
with a physiological sodium chloride concentration of 150 mM
NaCl using ultrapure water (Millipore, Billerica, MA, USA;
18.2 MΩ cm). Fe(III) hTF/2N was expressed in baby hamster
kidney cells and purified from the tissue culture medium as
described previously.25 The purity of the hTF/2N was con-
firmed by SDS-polyacrylamide gel electrophoresis and electro-
spray mass spectrometry. To remove the Fe(III), Fe(III) hTF/2N
was added to an excess of 0.5 M sodium citrate, 1 mM nitrilo-
triacetic acid (NTA) and 1 mM EDTA (ethylenediaminetetraace-
tate) (pH 4.9) and incubated at room temperature for
10 minutes. The resulting apo-hTF/2N was purified using 22
filtration cycles with Amicon Centrifugal Filter Units, 10 kDa
(6500 rpm). The protein concentration of the apo-hTf/2N stock
solution was determined by UV/Vis spectroscopy at λ = 280 nm
using an extinction coefficient of ε = 38 500 M−1 cm−1.26
The Cm(III) stock solution used for the TRLFS studies
(c(Cm) = 3.33 × 10−6 M in H2O) had an isotopic mass distri-
bution of 89.7% Cm-248, 9.4% Cm-246, ≤1% Cm-243, Cm-244,
Cm-245 and Cm-247. The Cm(III) concentration of the TRLFS
samples was fixed at 1.00 × 10−7 M by adding 30 µl of the
Cm(III) stock solution to 970 µl of a Tris-HCl buffered hTf/2N
solution with a concentration of 4.85 × 10−6 M resulting in a final
hTf/2N concentration of 5.00 × 10−6 M. Complexation studies
were carried out at varying pH values between 4.0 and 11.0
using NaOH and HCl solutions of different concentrations
(1.0 M, 0.5 M, 0.1 M, and 0.01 M). TRLFS measurements were
performed at room temperature (296 K) and physiological
temperature (310 K). For the measurements at physiological
carbonate concentration the samples were prepared with
Tris buffer containing 25 mM NaHCO3.
Time-resolved laser fluorescence spectroscopy (TRLFS)
TRLFS was performed using a Nd-YAG (Continuum Surelite
Laser) pumped dye laser system (NARROWscan D-R Dye Laser)
with a repetition rate of 10 Hz. For excitation of Cm(III) a wave-
length of 396.6 nm was used. Emission spectra were recorded
after a delay of 1 μs to discriminate short-lived fluorescence of
organic compounds. The pulse width was set to 1 ms. After
spectral decomposition by a spectrograph (Shamrock 303i)
with a 1199 lines mm−1 grating the spectra were recorded with
an ICCD camera (iStar Gen III, ANDOR) containing an inte-
grated delay controller. For better comparison all spectra are
normalized to the same peak area.
For lifetime measurements, the delay time between the
laser pulse and the detection of the fluorescence emission was
increased continuously with time intervals of Δt = 20 µs. The
lifetime τ is obtained by fitting the fluorescence intensity I as a
function of the delay time τ according to
IðλÞ ¼ I0ðλÞet=τ ð1Þ
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with the initial intensity I0 at t = 0. Using the Kimura equation
n H2Oð Þ ¼ 0:65 1
τ
 0:88 ð2Þ
the number of water molecules n(H2O) in the first coordi-
nation sphere is obtained from the fluorescence lifetime
τ (in ms).27,28
Results and discussion
Complexation of Cm(III) with hTf/2N at room temperature and
ambient carbonate concentration
Complexation of Cm(III) with hTf/2N as a function of
pH was investigated at ambient carbonate concentration
(c(carbonate)tot = 0.23 mM) and room temperature (296 K)
using two samples with an initial pH of 7.4 corresponding to
physiological blood conditions. The pH of the samples was
adjusted stepwise with HCl or NaOH, respectively. At each pH
step, a fluorescence spectrum was recorded (Fig. 1, top). The
spectra display a strong pH dependency of the complexation
reaction. Up to pH 7.4 the system is dominated by the Cm(III)
aquo ion, displaying an emission band at λmax = 593.8 nm.
29–31
With increasing pH, an emission band at λmax = 598.7 nm
increases which is attributed to the first Cm(III) hydrolysis
species Cm(OH)2+.32 Above pH 7.7 a Cm(III) hTf/2N complex
species is formed and becomes the dominant species for
pH ≥ 8.3. The spectra display a sharp emission band with
an emission maximum at λmax = 620.3 nm and a hot band at
λmax = 603.1 nm. Furthermore, the spectra show the presence
of a small amount of a Cm(III) EDTA species displaying an
emission maximum at λmax = 603.8 nm.
31 The EDTA impurity
has its origin in the purification process of apo-hTf/2N.
The emission band of the Cm(III) hTf/2N complex species is
identical to that of the Cm(III) transferrin species II with
Cm(III) bound at the C-terminal binding site observed in previous
studies.15,16,21 This species is characterized by very sharp emis-
sion bands at λmax = 619.9 nm and λmax = 602.9 nm (hot band).
The bathochromic shift of the emission band of 26 nm relative
to the emission band of the Cm(III) aquo ion is extraordinary
and confirms complexation of Cm(III) at the Fe(III) binding site
of the protein.15 The fluorescence lifetime of the emission band
of the Cm(III) hTf/2N species is determined to be τ = 217 ± 5 µs
which is in very good agreement with the value of the Cm(III)
transferrin species II (τ = 221 ± 5 µs) and corresponds to
two quenching water molecules in the first coordination
sphere.15,16,27,28 Assuming an overall coordination number of
nine for Cm(III), the TRLFS results indicate that the first
coordination sphere of Cm(III) complexed with transferrin as
well as with hTf/2N is composed of four amino acid ligands
from the protein, two H2O molecules and three additional
ligands (e.g. synergistic anions like carbonate).15,16 These
results show that the coordination environment of Cm(III) com-
plexed at the C-terminal Fe(III) binding site of transferrin is
identical to that of Cm(III) in the hTf/2N complex. The experi-
mental conditions of our previous measurements with trans-
ferrin ensure exclusive complexation of Cm(III) at the binding
site of the C-lobe whereas complexation occurs at the N-termi-
nal binding site with hTf/2N. Hence, our results confirm the
similarity of the coordination environment of the binding sites
in the N- and C-lobe of the protein.
In addition to the Cm(III) transferrin species II, the studies
on the complexation of Cm(III) with transferrin reveal the pres-
ence of an unspecific and only partially bound Cm(III) transfer-
rin species with five water molecules and four additional
ligands in the first coordination sphere (Cm(III) transferrin
species I) which is formed in the pH range from 3.5 to 9.7.15 In
contrast to the measurements with transferrin, no unspecific
Cm(III) species is formed with hTf/2N. Instead the first Cm(III)
hydrolysis species Cm(OH)2+ is formed in this pH range. This
indicates that the binding of Cm(III) either occurs on the
C-lobe or amino acids from both lobes are involved in the for-
mation of the Cm(III) transferrin species I.
The fluorescence spectra of the pure components (the
Cm(III) aquo ion, Cm(OH)2+, Cm(III) EDTA and the Cm(III) hTf/2N
species, Fig. 1 bottom) were determined from the pH
Fig. 1 Top: normalized fluorescence spectra of the Cm(III) hTf/2N
complexation at ambient carbonate concentration and room tempera-
ture in the pH range between 4.0 and 11.0; bottom: normalized fluor-
escence spectra of the Cm(III) aquo ion, the first Cm(III) hydrolysis
species, Cm(III) EDTA and the Cm(III) hTf/2N species; c(Cm) = 1.0 × 10−7 M,
c(hTf/2N) = 5.1 × 10−6 M, 10 mM Tris, T = 296 K.
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dependent fluorescence spectra. They were used to determine
the fractions of the four species at various pH values by peak
deconvolution of the emission spectra. The fluorescence inten-
sity factors ( fi factors) which describe the decrease or increase
of the fluorescence intensity relative to a reference species, in
this case the Cm(III) aquo ion, have been determined for all
Cm(III) species to be around 1 ± 0.5. This means that there is
no significant decrease or increase of the fluorescence inten-
sity upon complexation. Nevertheless, the fluorescence inten-
sity factors are taken into account for the calculation of the
concentration ratios but the speciation in dependence of pH
(species distribution, Fig. 2) shows no significant change upon
consideration of the fi factors. The Cm(III) aquo ion is present
up to pH 8.3, its concentration decreases with increasing pH,
whereas the fraction of the first Cm(III) hydrolysis species
Cm(OH)2+ increases. It is the dominating species in the pH
range from 6.5 to 8.2. At pH ≥ 7.4, the Cm(III) hTf/2N species is
formed. The formation of this species corresponds to the for-
mation of the Cm(III) transferrin species II.15 Both species are
formed at pH values above 7.4 which underlines the similarity
of the C- and N-terminal binding sites. Since the maximum
ratio of the Cm(III) EDTA species is about 5%, it has no signifi-
cant impact on the speciation and can be neglected.
Kinetics of the complexation reaction and stability of the
Cm(III) hTf/2N complex
Many chelating ligands (such as DOTA (1,4,7,10-tetraazacyclo-
dodecane-1,4,7,10-tetraacetic acid)) show slow complexation
kinetics.33–36 Since the effective ionic radius of Cm(III) is about
two times larger than that of Fe(III), it is expected not to fit
exactly into the C- and N-terminal Fe(III) binding sites of trans-
ferrin which might result in slow complexation kinetics.37
Therefore, the kinetics of the complexation of Cm(III) with
hTf/2N was analyzed at different pH values in the time range
from 0 to 189 hours. Fig. 3 depicts the normalized fluo-
rescence spectra of two Cm(III) hTf/2N samples at pH 8.0 (top)
and 10.0 (bottom) with time. Up to a period of 24 hours, the
spectra do not change significantly with time which indicates
fast kinetics of the complex formation. At both pH values, equili-
brium was reached after five minutes. This is in good agreement
with the data on the kinetics of the complexation of Cm(III) at the
C-terminal binding site of transferrin at pH 7.4 and 9.015 and
confirms fast complexation of Cm(III) at the C- and the N-termi-
nal Fe(III) binding sites. Therefore, measurements without
long-lasting equilibration periods are legitimate for all studies
on the interaction of Cm(III) with transferrin and hTf/2N.
To investigate the stability of the Cm(III) hTf/2N complex
species, fluorescence spectra were recorded after long equili-
bration times. The spectra of the Cm(III) transferrin species
I and II at pH 7.4 and 9.0 observed in our previous study are
unaltered up to 96 hours which indicates the formation of very
stable complexes.15 In contrast, the spectra of Cm(III) with
hTf/2N at pH 8.0 and 10.0 start to change after one day. The
emission band of the Cm(III) hTf/2N species at λmax = 620.3 nm
decreases significantly, in particular at pH 10.0, which indi-
cates decomplexation of Cm(III) in the time range from
24–189 hours. The results show that the Cm(III) complex
Fig. 2 Speciation of Cm(III) with hTf/2N as a function of pH at ambient
carbonate concentration and room temperature (the curves do not rep-
resent mathematical fits but are for guidance only); c(Cm) = 1.0 × 10−7 M
and c(hTf/2N) = 5.1 × 10−6 M, 10 mM Tris, T = 296 K.
Fig. 3 Normalized fluorescence spectra of the Cm(III) hTf/2N complexa-
tion at room temperature and ambient carbonate concentration at pH
8.0 (top) and pH 10.0 (bottom) as a function of time; c(Cm) = 1.0 × 10−7 M
and c(hTf/2N) = 5.0 × 10−6 M, 10 mM Tris, time range 0–189 h.
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formed with the intact transferrin is more stable than that
formed with the half molecule. Although the same amino
acid residues are present at both binding sites the primary
structure of the protein strain is not identical for the C- and
N-lobe4 and the stability constants, which are a measure for
the complex stability, differ significantly for complexation of
Cm(III) at the C- and N-terminal binding sites of transferrin
(log KC = 8.8 ± 0.3 and log KN = 7.0 ± 0.1 at pH 8.6).
16 This is
also reflected in the increased stability of Cm(III) bound at the
C-terminal binding site of transferrin in comparison with the
Cm(III) hTf/2N species. The absence of the second lobe seems
to have a significant influence on the stability of the protein
itself. Decomplexation occurs in the whole pH range in which
the Cm(III) hTf/2N species is present in solution, but the effect
is significantly higher when the pH is increased. Hence, the
deprotonation of amino acid residues which might change the
structure of hTf/2N seems to lead to a further decrease of the
stability of the half molecule.
Complexation of Cm(III) with hTf/2N at physiological
temperature
The complexation of Cm(III) with hTf/2N as a function of pH
was investigated at ambient carbonate concentration and physio-
logical temperature (310 K). The normalized fluorescence
spectra in the pH range from 4.0 to 11.0 (data not shown)
are comparable to those observed at room temperature.
They display the emission bands of the Cm(III) aquo ion
(λmax = 593.9 nm), the first Cm(III) hydrolysis species
(λmax = 598.7 nm), the Cm(III) EDTA species (λmax = 603.5 nm)
and the Cm(III) hTf/2N species (λmax = 619.9 nm, hot band at
λmax = 603.2 nm) which are formed successively with increasing pH.
The species concentrations in dependence of pH (species
distribution, Fig. 4) have been determined using the fractions
of the different Cm(III) species derived from peak deconvolu-
tion and the fluorescence intensity factors which are around
1 ± 0.5. The increase of the temperature from 296 K to 310 K has
a significant impact on the formation of the different Cm(III)
species. They are formed at pH values that are about 0.5 units
lower than the respective pH values at room temperature
(Fig. 2). At physiological temperature, the Cm(III) hTf/2N
species is formed above pH 7.0 whereas the formation starts at
pH ≥ 7.4 at room temperature conditions. This is comparable
to the difference in the formation of the Cm(III) transferrin
species II at these two temperatures.15 At 310 K, complex for-
mation also occurs at pH values that are 0.5 units lower than
the respective pH values at room temperature. The analogy of
the temperature dependency of the Cm(III) complexation with
hTf/2N and transferrin again underlines the similarity of the
C- and N-terminal binding sites.
Complexation of Cm(III) with hTf/2N at physiological
carbonate concentration
In order to study the influence of carbonate on the complexa-
tion of Cm(III) with hTf/2N, the complex formation was studied
as a function of pH at physiological carbonate concentration
(c(carbonate)tot = 25 mM). The term physiological carbonate
concentration describes a total concentration of the species
CO3
2−, HCO3
− and CO2(aq.) of c(carbonate)tot = 25 mM with the
speciation of CO3
2−, HCO3
− and CO2(aq.) depending on the
pH.21 Fig. 5 (top) shows the normalized fluorescence spectra
in the pH range from 4.0 to 11.0. At low pH the spectra
are dominated by the emission band of the Cm(III) aquo ion
(λmax = 593.9 nm). In contrast to the measurements at ambient
carbonate concentration, the emission band of the first Cm(III)
hydrolysis species is not observed under physiological carbo-




3− with emission maxima at
λmax = 598.8 nm, 603.2 nm and 605.8 nm are formed.
32 Com-
parison with blank solutions (without hTf/2N) in the same pH
range proves that these emission bands result from Cm(III) car-
bonate interactions and do not represent additional transfer-
rin species. The Cm(III) hTf/2N species with λmax = 619.7 nm is
formed at pH ≥ 10.5 which indicates a distinct competition
between carbonate and hTf/2N. Fig. 5 (bottom) shows the fluo-




3− and Cm(III) hTf/2N
species). As shown in Fig. 6 (top), the fraction of the Cm(III)
aquo ion decreases with increasing pH whereas up to 90% of




the speciation in the pH range from 5.8 to 7.2 and from 7.2 to
8.9, respectively. Additionally, the Cm(CO3)3
3− complex is
formed in the pH range from 7.7 to 11.0. The Cm(III) hTf/2N
species forms above pH 10.0 at physiological carbonate con-
ditions. In comparison, at ambient carbonate concentration,
the complex formation starts at a significantly lower pH value
(pH 7.4). Hence, an increase of the carbonate concentration
suppresses the formation of the Cm(III) hTf/2N species signifi-
cantly. This indicates that carbonate complexation is an impor-
tant competition reaction to the formation of the Cm(III)
hTf/2N species which has to be considered when complexation
studies with hTf/2N are performed at physiological conditions.
Fig. 4 Speciation of Cm(III) with hTf/2N as a function of pH at
ambient carbonate concentration and physiological temperature (the
curves do not represent mathematical fits but are for guidance only);
c(Cm) = 1.0 × 10−7 M and c(hTf/2N) = 5.1 × 10−6 M, 10 mM Tris, T = 310 K.
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In addition to the measurements at room temperature, the
complexation of Cm(III) with hTf/2N as a function of pH was
also studied at physiological carbonate concentration (c(carbo-
nate)tot = 25 mM) and physiological temperature (310 K). The
spectra are very similar to those observed at room temperature
conditions. They depict the emission bands of the Cm(III) aquo




3− and the Cm(III) hTf/2N species which are
formed successively with increasing pH. The species distri-
bution (Fig. 6, bottom) shows that the Cm(III) aquo ion domi-




3− species are formed suc-
cessively. Compared to room temperature conditions the for-
mation of the Cm(III) carbonate species starts at slightly lower
pH values. Above pH 9.3 the concentration of the Cm(III) hTf/2N
species increases continuously. In contrast, the formation of the
Cm(III) hTf/2N species at room temperature does not occur until
pH 10.0. Hence, an increase of the temperature favors the com-
plexation of Cm(III) with hTf/2N at lower pH values.
The speciation of Cm(III) hTf/2N complexation was com-
pared to the measurements of Cm(III) transferrin at the same
conditions.21 While the spectroscopic data on the complexa-
tion of Cm(III) with hTf/2N and at the C-terminal binding site
of transferrin agree very well at ambient carbonate concen-
tration (complex formation starts at pH 7.4), the species distri-
butions reveal significant differences at physiological
carbonate concentration: at room temperature, the Cm(III)
transferrin species II is formed at pH ≥ 7.0.21 This indicates
that an increase of carbonate favors the formation of the Cm(III)
transferrin species II at lower pH values, with carbonate acting as
a synergistic anion for Cm(III) complexation at the C-terminal
binding site of transferrin. At higher pH (pH ≥ 7.4), the
competing effect of carbonate plays a distinct role resulting in
a decrease of the fractions of the Cm(III) transferrin species II.21
In the case of hTf/2N, carbonate complexation suppresses the
formation of the Cm(III) hTf/2N species significantly, even at
low pH conditions. For that reason, this species is not formed
until pH > 10.0 at physiological carbonate concentration. In
general, carbonate complexation is a competing reaction for
both Cm(III) complexation with hTf/2N and at the C-terminal
Fig. 5 Top: normalized fluorescence spectra of the Cm(III) hTf/2N com-
plexation at physiological carbonate concentration and room tempera-
ture in the pH range from 4.0 to 11.0; bottom: normalized fluorescence
spectra of the Cm(III) aquo ion, the Cm(III) carbonate species and the
Cm(III) hTf/2N species; c(Cm) = 1.0 × 10−7 M, c(hTf/2N) = 5.1 × 10−6 M
and c(carbonate)tot = 2.5 × 10
−2 M, 10 mM Tris, T = 296 K.
Fig. 6 Speciation of Cm(III) with hTf/2N as a function of pH at
physiological carbonate concentration and room temperature (top) and
physiological temperature (bottom); the curves do not represent
mathematical fits but are for guidance only; c(Cm) = 1.0 × 10−7 M,
c(hTf/2N) = 5.1 × 10−6 M, c(carbonate)tot = 2.5 × 10
−2 M, 10 mM Tris,
T = 296 K (top) and T = 310 K (bottom).
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binding site of transferrin but the effect is significantly higher
for the half molecule.
There is only deficient knowledge concerning the competi-
tive effect of carbonate on the complexation of metal ions to
transferrin. Nevertheless, the competition between carbonate
and transferrin has been observed in previous studies for
some lanthanide and actinide ions.38–41 Based on complexa-
tion studies of Gd(III) with transferrin in vitro, Zak and Aisen
suggest that transferrin may not be an important carrier
protein for Gd(III) in vivo because of the formation of Gd(III)
carbonate complexes.41 Taylor et al. reported that only about
20% of Eu(III), Yb(III), Am(III) and Cm(III) are bound to transfer-
rin in vivo which is also attributed to the competition with
carbonate.39,40
Although the species distributions reveal significant differ-
ences in the complexation behavior of Cm(III) with the C-lobe
of transferrin and hTf/2N at physiological carbonate concen-
tration, the temperature dependency of the Cm(III) hTf/2N
complexation reaction is comparable to the data on Cm(III)
hTf/2N and Cm(III) transferrin interaction at ambient carbo-
nate concentration. In general, at physiological temperature
(310 K) the Cm(III) complexes with hTf/2N and the C-terminal
binding site of transferrin are formed at pH values that are 0.5
units lower than the respective pH values at room temperature
(valid for ambient and physiological carbonate conditions).
Hence, an increase of the temperature favors the complexation
of Cm(III) with hTf/2N as well as at the C-terminal binding site
of transferrin at lower pH values. This indicates that Cm(III)
transferrin and Cm(III) hTf/2N complexation are endothermic
and entropy-driven reactions.
Because of the potential transport of actinides into cells,
the complexation of Cm(III) with hTf/2N (N-lobe) and transfer-
rin (C-lobe) at physiological conditions (pH 7.4, T = 310 K,
c(carbonate)tot = 25 mM) is of particular interest. In the case of
hTf/2N, only the Cm(CO3)
+ and Cm(CO3)2
− species are formed
under physiological conditions whereas the formation of the
Cm(III) hTf/2N species is completely suppressed. In contrast,




3− and 15% of
the Cm(III) transferrin species II with Cm(III) bound at the
C-terminal binding site under the same conditions. Though the
fraction of the Cm(III) transferrin species II is low compared to
the fraction of the Cm(III) carbonate species, a complex with
Cm(III) bound at the C-terminal binding site of transferrin
might be recognized by the receptor followed by endocytosis
which could be a possible pathway for the distribution of Cm(III)
in the human body. In general, carbonate is a competitive
ligand for both hTf/2N and transferrin but the impact on the
Cm(III) hTf/2N species is significantly higher compared to Cm(III)
complexation at the C-terminal binding site of transferrin.
The different complexation behavior of hTf/2N and the C-lobe
of transferrin at physiological carbonate concentration might
either result from the thermodynamic difference of the
binding sites (log KC = 8.8 ± 0.3 and log KN = 7.0 ± 0.1 at pH
8.6),16 or from the fact that the presence or absence of the
second lobe might have a significant impact on the stability of
the protein itself as well as on the regarding Cm(III) complexes.
Nevertheless, the differences in the complexation behavior of
Cm(III) with hTf/2N and transferrin underline the inequality of
the C- and N-terminal binding sites.
Conclusions
In the present study, the complexation of Cm(III) with the
recombinant N-lobe of human serum transferrin (hTf/2N) was
investigated using TRLFS. The results were compared to the
measurements on Cm(III) complexation at the C-terminal
binding site of transferrin from previous studies resulting in
detailed information on the complexation properties of the C-
and N-terminal binding sites.15,21 The spectroscopic character-
istics of the emission bands show that the Cm(III) hTf/2N
species is comparable to the Cm(III) transferrin species II (Cm(III)
complexed at the C-terminal site) which indicates the simi-
larity of the coordination environment of the C- and N-termi-
nal binding sites. In both complexes Cm(III) is coordinated by
four amino acid residues of the protein, two H2O molecules
and three additional ligands (e.g. synergistic anions like
carbonate).15
Measurements at physiological carbonate concentration
reveal that the synergistic anion carbonate is a competitive
ligand for complexation of Cm(III) with hTf/2N. This is compar-
able to the influence of carbonate on Cm(III) transferrin but
the impact on the Cm(III) hTf/2N species (N-lobe) is signifi-
cantly higher compared to Cm(III) complexation at the C-termi-
nal binding site of transferrin. Hence, Cm(III) forms more
stable complexes with the C-terminal binding site of transfer-
rin compared to hTf/2N which is in good agreement with the
thermodynamic difference of the binding sites.16 Furthermore,
the presence of a second lobe seems to improve the stability of
the protein itself and the Cm(III) complexes significantly.
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